Completed PHASE1 INTERVENTIONAL 4-arm NCT04815993

Pharmacokinetics, Safety, and Tolerability of SYN-020

A Single Ascending Dose Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN-020 Delayed Release Capsules in Healthy Subjects

Sponsor: Spaulding Clinical Research LLC

Conditions Enteritis Caused by Radiation (Disorder)

Interventions SYN-020 delayed release capsule

Updated 6 times since 2021 Last updated: Nov 18, 2024 Started: Mar 22, 2021 Primary completion: May 18, 2021 Completion: Sep 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Enteritis Caused by Radiation (Disorder) and is currently completed. Spaulding Clinical Research LLC leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Dec 2024 — Present [monthly]

Completed PHASE1
Sep 2024 — Dec 2024 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Apr 2023 — Jul 2024 [monthly]

Completed PHASE1
Nov 2021 — Apr 2023 [monthly]

Completed PHASE1

Status: Recruiting → Completed

▶ Show 1 earlier version

Apr 2021 — Nov 2021 [monthly]

Recruiting PHASE1

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Spaulding Clinical Research LLC
Theriva Biologics, Inc.

Data source: Theriva Biologics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• West Bend, United States